Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
1.410
-0.055 (-3.75%)
May 6, 2026, 5:22 PM CET
-56.07% (1Y)
| Market Cap | 42.86M -47.4% |
| Revenue (ttm) | 32.78M -21.0% |
| Net Income | -28.48M |
| EPS | -0.98 |
| Shares Out | 30.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 85,394 |
| Open | 1.470 |
| Previous Close | 1.465 |
| Day's Range | 1.390 - 1.470 |
| 52-Week Range | 0.760 - 3.400 |
| Beta | 1.22 |
| RSI | 74.12 |
| Earnings Date | Apr 15, 2026 |